Insilico Medicine is an American biotechnology company that combines big data analytics, genomics, and deep learning for in silico medicine (computational medicine) discovery. The company has collaborated with Astellas Pharma Inc. to utilize Insilico Medicine’s novel generative AI technology.
The aim behind this technology is to accelerate the development of candidates against a challenging target family. Applying Astellas’ expertise in drug discovery and Insilico Medicine’s AI platform is the basis of this collaboration.
Astella is seen as a leader in the development and acquisition if new emerging technology and is a lead innovator in drug discovery. Insilico Medicine has seen a lot of growth in performance and quality over the last few years. This collaboration between Astellas’ scientists and Insilico’s meta-learning, reinforcement learning, and genetic algorithms might result in finding a cure for a challenging target family.
In this collaboration, Insilico Medicine will help Astellas characterize, optimize, and synthesize the molecules generated using AI and will receive milestones and an upfront payment.
Being a world leader in AI for drug discoveries, Insilico Medicine, and Astellas’ experienced drug discovery team might turn out to be one of the most innovative pharmaceutical companies’ collaboration.
#AIMonks #AI #InsilicoMedicine #AstellasPharmaInc #MetaLearning #Genetic #algorithm #ReinforcementLearning #Drug #Discoveries #Technology
0 Comments